A Food and Drug Administration (FDA) letter warning a company about its marketing of injectable CBD products has led to a voluntary recall that the federal agency announced on Wednesday. Biota Biosciences received the letter last month, with FDA directing the firm to cease sales of its line of CBD vials, which it markets as … Continue reading Company Recalls Injectable CBD Products Following FDA Warning Letter